Characteristics | Normal | Low HDL | aOR | 95.0 C.I. for OR | p-value | |
---|---|---|---|---|---|---|
Mean ± S.D. | Mean ± S.D. | Lower | Upper | |||
N (%) | N (%) | |||||
Ethnicity | ||||||
Malay | 105 (23.3) | 285 (25.4) | 1.00 | Â | Â | Â |
Indian | 62 (13.7) | 96 (8.6) | 0.570 | 0.386 | 0.842 | 0.009 |
Chinese | 284 (27.8) | 739 (72.2) | 1.753 | 1.187 | 2.589 | 0.005 |
ARV medication | ||||||
Without PI | 382 (86.2) | 998 (90.1) | 1.00 | Â | Â | Â |
With PI | 61 (13.8) | 110 (9.9) | 1.449 | 1.037 | 2.024 | 0.029 |
Anti-hyperglycaemic Agents | Â | Â | Â | Â | Â | Â |
Not taking | 57 (12.6) | 91 (8.1) | 1.00 | Â | Â | Â |
Taking | 397 (87.4) | 1037 (91.9) | 1.636 | 1.152 | 2.323 | 0.006 |
Viral Load (copies/mL) | Â | Â | Â | Â | Â | Â |
<20 | 391 (86.1) | 979 (86.8) | 1.00 | Â | Â | Â |
>20 | 63 (13.9) | 149 (13.2) | 0.945 | 0.688 | 1.297 | 0.724 |
CD4 (cells/mm3) | Â | Â | Â | Â | Â | Â |
<200 | 25 (5.6) | 90 (8.0) | 1.00 | Â | Â | Â |
≥200 | 419 (94.4) | 1029 (92.0) | 0.682 | 0.432 | 1.078 | 0.099 |
TG (mmol/l) | 2.08 ± 1.37 | 3.23 ± 2.39 | 0.693 | 0.646 | 0.745 | 0.001 |
<5.17 | 95 (21.1) | 551 (48.9) | 1.00 | Â | Â | Â |
≥5.17 | 356 (78.9) | 576 (51.1) | 0.279 | 0.216 | 0.360 | 0.001 |
LDL (mmol/l) | 3.17 ± 1.01 | 2.64 ± 1.05 | 1.709 | 1.516 | 1.926 | 0.001 |
<3.36 | 349 (77.6) | 673 (59.7) | 1.00 | Â | Â | Â |
≥3.36 | 101 (22.4) | 454 (40.3) | 2.331 | 1.813 | 2.997 | 0.001 |
TC (mmol/l) | Â | Â | Â | Â | Â | Â |
<5.17 | 258 (56.8) | 466 (41.3) | 1.00 | Â | Â | Â |
≥5.17 | 196 (43.2) | 661 (58.7) | 1.867 | 1.498 | 2.327 | 0.001 |
Hepatitis | Â | Â | Â | Â | Â | Â |
No | 383 (84.4) | 1010 (89.5) | 1.00 | Â | Â | Â |
Yes | 71 (15.6) | 118 (10.5) | 0.630 | 0.459 | 0.865 | 0.004 |